GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » Cyclically Adjusted FCF per Share

Teva Pharmaceutical Industries (MEX:TEVA N) Cyclically Adjusted FCF per Share : MXN32.40 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted free cash flow per share for the three months ended in Mar. 2025 was MXN-4.095. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN32.40 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Teva Pharmaceutical Industries's average Cyclically Adjusted FCF Growth Rate was -26.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -12.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -9.80% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Teva Pharmaceutical Industries was 42.60% per year. The lowest was -12.40% per year. And the median was 12.10% per year.

As of today (2025-06-30), Teva Pharmaceutical Industries's current stock price is MXN317.43. Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN32.40. Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF of today is 9.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Teva Pharmaceutical Industries was 22.86. The lowest was 1.80. And the median was 4.68.


Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.87 57.02 48.01 37.36 34.79

Teva Pharmaceutical Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.01 36.96 36.95 34.79 32.40

Competitive Comparison of Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF falls into.


;
;

Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-4.095/134.9266*134.9266
=-4.095

Current CPI (Mar. 2025) = 134.9266.

Teva Pharmaceutical Industries Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 23.946 100.684 32.090
201509 18.094 100.392 24.318
201512 26.833 99.792 36.280
201603 22.528 100.470 30.254
201606 15.840 101.688 21.018
201609 24.366 101.861 32.276
201612 -4.921 101.863 -6.518
201703 -1.222 102.862 -1.603
201706 4.301 103.349 5.615
201709 10.403 104.136 13.479
201712 11.443 104.011 14.844
201803 23.743 105.290 30.426
201806 0.502 106.317 0.637
201809 5.182 106.507 6.565
201812 2.936 105.998 3.737
201903 -0.231 107.251 -0.291
201906 -5.963 108.070 -7.445
201909 2.820 108.329 3.512
201912 7.243 108.420 9.014
202003 3.787 108.902 4.692
202006 2.980 108.767 3.697
202009 3.306 109.815 4.062
202012 2.816 109.897 3.457
202103 -10.248 111.754 -12.373
202106 1.885 114.631 2.219
202109 7.101 115.734 8.279
202112 5.640 117.630 6.469
202203 -3.705 121.301 -4.121
202206 -0.072 125.017 -0.078
202209 7.568 125.227 8.154
202212 14.556 125.222 15.684
202303 -4.591 127.348 -4.864
202306 3.138 128.729 3.289
202309 -2.210 129.860 -2.296
202312 16.155 129.419 16.842
202403 -3.665 131.776 -3.753
202406 0.097 132.554 0.099
202409 9.472 133.029 9.607
202412 8.203 133.157 8.312
202503 -4.095 134.927 -4.095

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Teva Pharmaceutical Industries  (MEX:TEVA N) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=317.43/32.40
=9.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Teva Pharmaceutical Industries was 22.86. The lowest was 1.80. And the median was 4.68.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines